Autifony Therapeutics
About:
Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.
Website: http://www.autifony.com
Top Investors: Innovate UK, SV Health Investors, Pfizer Venture Investments, Imperial Innovations, UCLB
Description:
Autifony Therapeutics Limited, a biotechnology company, develops medicines to treat hearing disorders such as hearing loss and tinnitus. The company was incorporated in 2011 and is based in London, United Kingdom.
Total Funding Amount:
$39.7M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
London, England, United Kingdom
Founded Date:
2011-01-01
Contact Email:
info(AT)autifony.com
Founders:
Charles Large
Number of Employees:
11-50
Last Funding Date:
2017-03-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai